| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 9209 | 2021 |
| 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European … M Glikson, JC Nielsen, MB Kronborg, Y Michowitz, A Auricchio, ... EP Europace 24 (1), 71-164, 2022 | 1539 | 2022 |
| Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging SD Anker, W Doehner, M Rauchhaus, R Sharma, D Francis, C Knosalla, ... Circulation 107 (15), 1991-1997, 2003 | 956 | 2003 |
| Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure JW Swan, SD Anker, C Walton, IF Godsland, AL Clark, F Leyva, ... Journal of the American College of Cardiology 30 (2), 527-532, 1997 | 654 | 1997 |
| The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function … YT Tan, F Wenzelburger, E Lee, G Heatlie, F Leyva, K Patel, M Frenneaux, ... Journal of the American College of Cardiology 54 (1), 36-46, 2009 | 592 | 2009 |
| Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure F Leyva, S Anker, JW Swan, IF Godsland, CS Wingrove, TP Chua, ... European heart journal 18 (5), 858-865, 1997 | 591 | 1997 |
| Uric acid in chronic heart failure: a marker of chronic inflammation F Leyva, SD Anker, IF Godsland, M Teixeira, PG Hellewell, WJ Kox, ... European heart journal 19 (12), 1814-1822, 1998 | 507 | 1998 |
| Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure SD Anker, PP Ponikowski, AL Clark, F Leyva, M Rauchhaus, M Kemp, ... European heart journal 20 (9), 683-693, 1999 | 485 | 1999 |
| Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk F Leyva, IF Godsland, M Ghatei, AJ Proudler, S Aldis, C Walton, S Bloom, ... Arteriosclerosis, thrombosis, and vascular biology 18 (6), 928-933, 1998 | 438 | 1998 |
| Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis A Di Marco, I Anguera, M Schmitt, I Klem, TG Neilan, JA White, M Sramko, ... JACC: Heart Failure 5 (1), 28-38, 2017 | 375 | 2017 |
| Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure W Doehner, M Rauchhaus, P Ponikowski, IF Godsland, S von Haehling, ... Journal of the American College of Cardiology 46 (6), 1019-1026, 2005 | 333 | 2005 |
| Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy F Leyva, RJ Taylor, PWX Foley, F Umar, LJ Mulligan, K Patel, ... Journal of the American College of Cardiology 60 (17), 1659-1667, 2012 | 292 | 2012 |
| Myocardial strain measurement with feature-tracking cardiovascular magnetic resonance: normal values RJ Taylor, WE Moody, F Umar, NC Edwards, TJ Taylor, B Stegemann, ... European Heart Journal–Cardiovascular Imaging 16 (8), 871-881, 2015 | 286 | 2015 |
| Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance F Leyva, PWX Foley, S Chalil, K Ratib, REA Smith, F Prinzen, A Auricchio Journal of Cardiovascular Magnetic Resonance 13 (1), 29, 2011 | 232 | 2011 |
| Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy S Chalil, PWX Foley, SA Muyhaldeen, KCR Patel, ZR Yousef, REA Smith, ... Europace 9 (11), 1031-1037, 2007 | 222 | 2007 |
| Insulin resistance in chronic heart failure JW Swan, C Walton, IF Godsland, AL Clark, AJS Coats, MF Oliver European Heart Journal 15 (11), 1528-1532, 1994 | 212 | 1994 |
| Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization … S Chalil, B Stegemann, S Muhyaldeen, K Khadjooi, REA Smith, PJ Jordan, ... Journal of the American College of Cardiology 50 (3), 243-252, 2007 | 197 | 2007 |
| Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry) M Gasparini, C Leclercq, M Lunati, M Landolina, A Auricchio, M Santini, ... JACC: Heart Failure 1 (6), 500-507, 2013 | 193 | 2013 |
| Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac … FM Fruhwald, A Fahrleitner-Pammer, R Berger, F Leyva, N Freemantle, ... European heart journal 28 (13), 1592-1597, 2007 | 188 | 2007 |
| Hyperleptinaemia in chronic heart failure: relationships with insulin F Leyva, SD Anker, K Egerer, JC Stevenson, WJ Kox, AJS Coats European heart journal 19 (10), 1547-1551, 1998 | 186 | 1998 |
Andrew J Stewart CoatsAcademic VP, Monash and Warwick UniversitiesVerified email at monash.edu
